
Victor R. Kostak
Examiner (ID: 9883)
| Most Active Art Unit | 2602 |
| Art Unit(s) | 2602, 2622, 2422, 2611, 2711, 2899, 2614 |
| Total Applications | 3434 |
| Issued Applications | 2950 |
| Pending Applications | 96 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19731951
[patent_doc_number] => 12209943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Isolated cell membrane potential detection system and method based on multi-spectral multi-parameter photostimulation
[patent_app_type] => utility
[patent_app_number] => 18/567880
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4315
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 395
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567880 | Isolated cell membrane potential detection system and method based on multi-spectral multi-parameter photostimulation | Sep 15, 2022 | Issued |
Array
(
[id] => 18149413
[patent_doc_number] => 20230023270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => APPLICATIONS OF BUTYLIDENEPHTHALIDE
[patent_app_type] => utility
[patent_app_number] => 17/932549
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/932549 | Applications of butylidenephthalide | Sep 14, 2022 | Issued |
| 17/941423 | PLATFORM AND METHOD FOR ENGINEERING A HUMAN ORGANOID REPLICA FOR REPRODUCTIVE SCREENING | Sep 8, 2022 | Abandoned |
Array
(
[id] => 18421504
[patent_doc_number] => 20230175967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => USE OF RAMAN SPECTROSCOPY TO MONITOR CULTURE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/885167
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885167 | Use of raman spectroscopy to monitor culture medium | Aug 9, 2022 | Issued |
Array
(
[id] => 19969864
[patent_doc_number] => 12338457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Biologically functional soft tissue scaffolds and implants
[patent_app_type] => utility
[patent_app_number] => 17/871149
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 31
[patent_no_of_words] => 13326
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871149 | Biologically functional soft tissue scaffolds and implants | Jul 21, 2022 | Issued |
Array
(
[id] => 18209965
[patent_doc_number] => 20230056226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEUROFIBROMATIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/835566
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835566 | COMPOSITIONS AND METHODS FOR TREATING NEUROFIBROMATIC DISORDERS | Jun 7, 2022 | Pending |
Array
(
[id] => 18886777
[patent_doc_number] => 11865536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Human lymphoid tissue-on-chip
[patent_app_type] => utility
[patent_app_number] => 17/730615
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 11030
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730615 | Human lymphoid tissue-on-chip | Apr 26, 2022 | Issued |
Array
(
[id] => 19216310
[patent_doc_number] => 20240181014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => USE OF AVIPTADIL ALONE OR IN COMBINATION WITH ALPHA LIPOIC ACID AS A THERAPEUTIC MEDICAMENT FOR POST-VIRAL INFECTION SYNDROME
[patent_app_type] => utility
[patent_app_number] => 18/556073
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556073
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556073 | USE OF AVIPTADIL ALONE OR IN COMBINATION WITH ALPHA LIPOIC ACID AS A THERAPEUTIC MEDICAMENT FOR POST-VIRAL INFECTION SYNDROME | Apr 19, 2022 | Pending |
Array
(
[id] => 19752886
[patent_doc_number] => 20250041451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => GENE THERAPY FOR HEARING LOSS
[patent_app_type] => utility
[patent_app_number] => 18/554160
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554160
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554160 | GENE THERAPY FOR HEARING LOSS | Apr 5, 2022 | Pending |
Array
(
[id] => 19128426
[patent_doc_number] => 20240133779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => HYDROGEL-BASED STAMPING FOR SOLUTION-FREE BLOOD CELL STAINING
[patent_app_type] => utility
[patent_app_number] => 18/548360
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548360 | HYDROGEL-BASED STAMPING FOR SOLUTION-FREE BLOOD CELL STAINING | Apr 1, 2022 | Pending |
Array
(
[id] => 19128426
[patent_doc_number] => 20240133779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => HYDROGEL-BASED STAMPING FOR SOLUTION-FREE BLOOD CELL STAINING
[patent_app_type] => utility
[patent_app_number] => 18/548360
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548360 | HYDROGEL-BASED STAMPING FOR SOLUTION-FREE BLOOD CELL STAINING | Mar 31, 2022 | Pending |
Array
(
[id] => 19218153
[patent_doc_number] => 20240182857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => METHOD FOR PRODUCING CELL SHEET
[patent_app_type] => utility
[patent_app_number] => 18/285006
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285006
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285006 | METHOD FOR PRODUCING CELL SHEET | Mar 28, 2022 | Pending |
Array
(
[id] => 19203104
[patent_doc_number] => 20240175003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => METHOD TO SELECTIVELY PERMEABILIZE AND/OR FRAGMENTIZE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/551165
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551165
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551165 | Method to selectively permeabilize and/or fragmentize cells | Mar 21, 2022 | Issued |
Array
(
[id] => 17719046
[patent_doc_number] => 20220211765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => USE OF STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS AND COMPOSITIONS THEREOF TO TREAT NEUROLOGICAL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/700458
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700458 | Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease | Mar 20, 2022 | Issued |
Array
(
[id] => 17838014
[patent_doc_number] => 20220275319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS
[patent_app_type] => utility
[patent_app_number] => 17/696904
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696904 | MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS | Mar 16, 2022 | Pending |
Array
(
[id] => 19172840
[patent_doc_number] => 20240158814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => DENDRITIC PEPTIDE CONJUGATED POLYMERS FOR EFFICIENT INTRACELLULAR DELIVERY OF NUCLEIC ACIDS TO IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/551095
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551095
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551095 | DENDRITIC PEPTIDE CONJUGATED POLYMERS FOR EFFICIENT INTRACELLULAR DELIVERY OF NUCLEIC ACIDS TO IMMUNE CELLS | Mar 16, 2022 | Pending |
Array
(
[id] => 18512463
[patent_doc_number] => 20230228667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => METHOD FOR ISOLATING PLACENTAL TROPHOBLAST CELLS FROM CERVICAL EXFOLIATED CELLS OF PREGNANT WOMAN
[patent_app_type] => utility
[patent_app_number] => 18/009740
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009740 | Method for isolating placental trophoblast cells from cervical exfoliated cells of pregnant woman | Mar 15, 2022 | Issued |
Array
(
[id] => 20453242
[patent_doc_number] => 12516294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Method for producing mesenchymal stem cells from living body-derived cell sample containing mesenchymal stem cells
[patent_app_type] => utility
[patent_app_number] => 17/680619
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 5951
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680619 | Method for producing mesenchymal stem cells from living body-derived cell sample containing mesenchymal stem cells | Feb 24, 2022 | Issued |
Array
(
[id] => 19410668
[patent_doc_number] => 12076461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Use of resected liver serum for whole liver-engineering
[patent_app_type] => utility
[patent_app_number] => 17/665955
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8632
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665955 | Use of resected liver serum for whole liver-engineering | Feb 6, 2022 | Issued |
Array
(
[id] => 19474091
[patent_doc_number] => 12104169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Chemical reprogramming to generate neuronal cells
[patent_app_type] => utility
[patent_app_number] => 17/587116
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 53
[patent_no_of_words] => 25142
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587116 | Chemical reprogramming to generate neuronal cells | Jan 27, 2022 | Issued |